ASML’s, Summer

ASML’s Summer of Contradictions: Analyst Bullishness Collides with Market Nerves Ahead of July 15 Report

Published on 07/10/2026 at 14:24 | Redaktion boerse-global.de

ASML shares drop 10.8% from record as Samsung miss and margin call spook market, but analysts raise targets on EUV monopoly and AI demand. High P/E of 64.7 raises caution.

ASML Stock Slips vs Analyst Upgrades: Semiconductor Cycle Debate
ASML’s Summer of Contradictions: Analyst Bullishness Collides with Market Nerves Ahead of July 15 Report Illustration mit AI erstellt übermittelt durch boerse-global.de

ASML finds itself in an unusual standoff. While the Dutch lithography titan’s stock has been sliding for over a week, a parade of analysts has been raising price targets to new heights. The divergence between the tape and the sell-side verdict is raising a simple question: whose reading of the semiconductor cycle is closer to the mark?

The numbers tell the story of the split. ASML shares closed Friday at €1,560, down 1.58% on the day and 4.18% lower over seven trading sessions. From the record high of €1,748 reached on June 30, the decline now stands at 10.76%. Yet year-to-date the stock is still up nearly 58%. The recent weakness has a clear catalyst: Samsung Electronics’ preliminary second-quarter results came in below elevated investor expectations, triggering a brief trading halt in Seoul and sending shockwaves through European chip-equipment suppliers. ASML, with annualized volatility of 64.53%, absorbed the brunt of the move.

Adding to the market noise was a margin-call cascade at Asian exchanges on July 9 that sent ASML’s shares briefly plunging more than 5% intraday. By the close, the stock had recovered to register a 4.21% gain, but the episode underscored the sector’s vulnerability to sudden liquidity-driven selloffs. That same day, South Korean memory giant SK Hynix made its Nasdaq debut, targeting roughly $28 billion in proceeds. Buried in its listing documents was a detail that reinforces ASML’s strategic position: SK Hynix intends to spend approximately 11.9 trillion won on EUV lithography systems from ASML, with deliveries scheduled through December 2027. The order highlights how deeply the world’s biggest memory-chip makers are tying their capacity expansion to ASML’s monopoly in extreme-ultraviolet technology.

Should investors sell immediately? Or is it worth buying Asml?

That monopoly underpins the analysts’ optimism. Bernstein’s David Dai raised his price target on July 6 from $1,971 to $2,623, reiterating an “Outperform” rating. He forecasts 91 EUV systems shipped in 2027 and 113 in 2028, arguing that AI-driven demand for advanced logic and DRAM capacity is outstripping earlier expectations. Morgan Stanley’s Lee Simpson followed on July 8, lifting his target from €1,660 to €1,830 with an “Overweight” call. Susquehanna had already pushed its target to €2,350 in late June, maintaining a “Positive” stance. The bull case extends beyond the immediate order book: the next-generation High-NA EUV systems, each costing around €350 million, are expected to become a significant revenue driver. Analysts project EUV revenue will grow at a 30% annual clip to €42.7 billion by 2030.

Yet the bearish counterargument is just as compelling — and rooted in ASML’s own valuation. The stock trades at a price-to-earnings ratio of roughly 64.71, leaving little room for disappointment. Some analysts now consider net orders more important than reported revenue as a gauge of future momentum. The critical threshold for the market is ASML’s ability to confirm a delivery roadmap of 90 to 100 EUV systems for 2027. Without that visibility, the lofty multiple becomes difficult to justify. Geopolitical risks add another layer of uncertainty. Export controls on China remain in place, and the rise of what observers call “technology nationalism” continues to cloud ASML’s sales to the world’s largest semiconductor market. A pullback in Samsung’s aggressive investment plans — or those of SK Hynix and Micron, which has budgeted $27 billion for fiscal 2026 — would directly threaten ASML’s growth assumptions for 2027.

All eyes now turn to the July 15 earnings report for the second quarter. ASML reiterated its annual revenue guidance of €36 billion to €40 billion back in April, citing supply that still lags demand. JPMorgan expects the company to post sales of €8.7 billion, up 13.1% year-over-year, with earnings per share of €6.67 and a gross margin around 51.7%. The real focus, however, will be on net orders and the management’s tone regarding 2027 capacity. If ASML can signal that order intake supports 90 to 100 EUV shipments next year — and perhaps offer encouraging updates on High-NA EUV adoption — the stock could break toward the upper end of analyst targets, in the $2,300–$2,623 range. A miss on net orders or a cautious note on capacity expansion, by contrast, would likely trigger a consolidation phase as the market reassesses the cyclical peak risk in semiconductor equipment.

The next fortnight will tell whether the analyst community’s conviction or the market’s recent jitters is the more reliable guide. July 15 is the moment of truth for ASML’s narrative — and for its investors.

Ad

Asml Stock: New Analysis - 10 July

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0010273215 | ASML’S | boerse | 69737576 |